Findings By Sylvester Researchers Point to New Therapeutic Target for Advanced Prostate Cancer
July 18, 2019
July 18, 2019
MIAMI, July 18 [TNSmedicalresearch] -- The University of Miami's Miller School of Medicine issued the following news:
The Burnstein lab at Sylvester Comprehensive Cancer Center, along with collaborators at Moffitt Cancer Center and the University of Florida Cancer Center, recently discovered that arginine vasopressin receptor type 1a (AVPR1a) can promote aggressive prostate cancer growth. While arginine vasopressin receptors are normally associated with the regulation of blood press . . .
The Burnstein lab at Sylvester Comprehensive Cancer Center, along with collaborators at Moffitt Cancer Center and the University of Florida Cancer Center, recently discovered that arginine vasopressin receptor type 1a (AVPR1a) can promote aggressive prostate cancer growth. While arginine vasopressin receptors are normally associated with the regulation of blood press . . .